#BIOSPAIN2026 | Encapsulation technologies: Driving the next generation of therapies 22/07/2026 Healthcare Personalized medicine International BioSpain The future of medicine will depend not only on discovering new drugs, but also on developing technologies capable of... AseBio
#BIOSPAIN 2026 | Galicia Bio: A Bioregion ready to compete, attract investment and lead th... 20/07/2026 Healthcare Industrial biotechnology Bioeconomy International BioSpain Román Rodríguez González, Regional Minister for Education, Science, Universities and Vocational Training of the Xunta de... AseBio
Join the BIOSPAIN 2026 Talent Day: Connecting Biotech Companies with Specialized Talent 03/07/2026 International BioSpain Talento The congress, which will take place in Bilbao from 29 September to 1 October, will dedicate its final day to the Talent... AseBio
Biobide's DNT assay validated by NIH and US-EPA 01/07/2026 Healthcare Drug discovery International A study led by NIEHS/NIH, with participation from Biobide, the US-EPA, the University of Konstanz, and the IUF-Leibniz... Partners - Biotechnology Assets
Fecundis HyperSperm technology increases the number and quality of embryos produced thro... 30/06/2026 Healthcare Access to innovation International A new clinical trial shows that HyperSperm technology, developed by the biotech start-up Fecundis, based at the... Partners - Parc Científic de Barcelona
BIOSPAIN 2026 and the UK: Connecting two leading biotech ecosystems to drive innovation an... 24/06/2026 Healthcare International BioSpain The United Kingdom will be the Guest Nation at BIOSPAIN 2026, underscoring the event’s growing international relevance... AseBio
The European Council advances the Biotech Act I legislative process 22/06/2026 International EU projects The EU EPSCO Council took a step forward in the legislative process of the Biotech Act I by agreeing on a common... AseBio
Cardiovascular Device Development: KOL Insights for Innovators Online Del 16/07/2026 17:00 to 16/07/2026 18:00 Healthcare Access to innovation International
#VozBiotech | The industrial ownership of NGT-1 plants: a geostrategic challenge for Europ... 23/06/2026 Agriculture Gene editing International Rafael López, Head of Technology Transfer and Director of the PONS IP Office in Valencia. AseBio - PONS IP
